Aura Biosciences (AURA) Research & Development (2020 - 2026)

Aura Biosciences has reported Research & Development for 7 years, with the latest figure at $28.0 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 19.78% year-over-year to $28.0 million; the trailing twelve-month figure through Mar 2026 stood at $94.9 million (up 19.25% YoY), and the FY2025 full-year result was $90.3 million, up 23.19% from the prior year.
• Research & Development for Q1 2026 stood at $28.0 million, up from $21.9 million in the prior quarter.
• The five-year high for Research & Development was $28.0 million in Q1 2026, with the low at $8.3 million in Q1 2022.
• Historically, Research & Development has averaged $17.6 million across 5 years, with a median of $17.0 million in 2024.
• Annual changes were most pronounced in 2022 — Research & Development soared 97.75% — and 2025, when it slipped 1.96%.
• Aura Biosciences' Research & Development stood at $13.2 million in 2022, then jumped by 54.12% to $20.3 million in 2023, then grew by 10.13% to $22.3 million in 2024, then fell by 1.96% to $21.9 million in 2025, then advanced by 27.69% to $28.0 million in 2026.
• The last three Research & Development figures came in at $28.0 million (Q1 2026), $21.9 million (Q4 2025), and $22.2 million (Q3 2025), per Business Quant data.